Beyond The Numbers: 15 Analysts Discuss Legend Biotech Stock
Beyond The Numbers: 15 Analysts Discuss Legend Biotech Stock
数字之外：15位分析师讨论传奇生物股票
Across the recent three months, 15 analysts have shared their insights on Legend Biotech (NASDAQ:LEGN), expressing a variety of opinions spanning from bullish to bearish.
在最近的三个月内，15位分析师分享了他们对传奇生物（NASDAQ: LEGN）的见解，表达了从看好到看淡的各种观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估，下表展示了过去30天内不断变化的情绪，并将其与之前的几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $76.73, a high estimate of $90.00, and a low estimate of $60.00. A decline of 1.15% from the prior average price target is evident in the current average.
分析师评估的12个月价格目标揭示了进一步的见解，包括平均目标为$76.73，最高估值为$90.00，最低估值为$60.00。当前平均目标较之前有1.15%的下降。
Exploring Analyst Ratings: An In-Depth Overview
分析师评级:深入了解
The analysis of recent analyst actions sheds...
分析师近期行动...
登录免费看全文
登录/注册